DILIsym Scientific Advisory Board A world-class Scientific Advisory Board The DILI-sim Initiative engages a world-class Scientific Advisory Board (SAB) for DILIsym development guidance. The DILI-sim Initiative SAB currently consists of 7 world-renowned scientists representing many scientific disciplines relevant to drug-induced liver injury. In addition, members of the SAB have extensive experience in the areas of medicine, pharmacology, and immunology with publications spanning numerous disciplines and journals. The SAB members provide strategic guidance and direction for our research and scientific programs, engaging individually with the DILIsym development team to address specific scientific areas, participate in DILIsym Review Sessions, and gather for an annual progress update. Board members are appointed in their personal capacity and not as representatives of their respective universities or of any other entities with which they may be affiliated. Meet our DILIsym Scientific Advisory Board Paul B Watkins Director David S Pisetsky Professor Kevin Park Professor Neil Kaplowitz Professor Robert A. Roth Professor Jack Uetrecht Professor Join Our Team .st0{fill:#FFFFFF;} View QSP/QST Workshops .st0{fill:#FFFFFF;} Peer-reviewed publications citing applications of DILIsym Services® products 08/20/2021 Quantitative Systems Toxicology Modeling Predicts that Reduced Biliary Efflux Contributes to Tolvaptan Hepatotoxicity Read More 06/17/2021 Quantitative Systems Pharmacology Modeling of Fibrotic Diseases Read More 10/22/2020 Application of the DILIsym® Quantitative Systems Toxicology drug-induced liver injury model to evaluate the carcinogenic hazard potential of acetaminophen Read More 10/05/2020 Quantitative Systems Toxicology Analysis of In Vitro Mechanistic Assays Reveals Importance of Bile Acid Accumulation and Mitochondrial Dysfunction in TAK-875-Induced Liver Injury Read More 06/24/2020 Mechanistic Investigations Support Liver Safety of Ubrogepant Read More View All Publications SOFTWARE ADMET Predictor® DDDPlus™ DILIsym® GastroPlus® IPFsym™ MedChem Designer™ MembranePlus™ MonolixSuite® NAFLDsym® RENAsym SERVICES Global Regulatory Strategies Liver Safety Modeling and Analysis Noncompartmental PK/TK Analysis PBPK Modeling and Simulation PK/PD Support PopPK & Exposure Response Modeling QSP Modeling of NAFLD & NASH Training and Workshops RESOURCE CENTER Blog Contact Support GastroPlus User Group Journal Articles PKPlus User Group Posters Product Brochures Software Installation Videos Webinars INVESTORS Board of Directors ESG Report Latest Presentations Press Releases SEC Filings Shareholder Information ABOUT Simulations Plus Contact Career Opportunities Leadership Partners and Collaborators Privacy Policy Vision, Mission & Values Events INDUSTRIES Chemicals Deep Machine Learning & Technology Food/Cosmetic Pharma + Biotech  © 2021 Simulations Plus. All rights reserved. Privacy Policy | Site Map | Terms of Use